Irving Investors Investor
Irving Investors focuses on disruptive technology and high growth opportunities.
.png)
Technology:
Cell_Therapies
Industry:
Finance, Financial Services, Venture Capital
Headquarters:
New York, New York, United States
Founded Date:
2009-01-01
Employees Number:
1-10
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture, Late Stage Venture, Seed
Number Of Exits:
15
Acquisitions Number:
15
Estimated Revenue:
$1M to $10M
Register and Claim Ownership